GSK Feb 2023 38.000 put
OPR - OPR Delayed price. Currency in USD
Add to watchlist
At close: 09:42AM EST
| Previous close | 2.8500 |
| Open | 2.8500 |
| Bid | 3.1000 |
| Ask | 3.3000 |
| Strike | 38.00 |
| Expiry date | 2023-02-17 |
| Day's range | 2.8500 - 2.8500 |
| Contract range | N/A |
| Volume | |
| Open interest | 931 |
- Zacks
GSK's Daprodustat Drug for Anemia Due to CKD Gets FDA Nod
GSK announces the FDA approval of daprodustat for the treatment of anemia due to chronic kidney disease (CKD) in adults on dialysis for at least four months.
- The Guardian
GSK boss warns UK life sciences at ‘tipping point’ despite Sunak’s R&D pledge
Emma Walmsley says ambition to be pharma superpower at risk unless improvements made in key areas
- Fool.co.uk
Earnings: are GSK shares a buy after a big earnings rise?
Do GSK shares provide one of the FTSE 100's most reliable dividends right now? Full-year 2022 results show steady progress. The post Earnings: are GSK shares a buy after a big earnings rise? appeared first on The Motley Fool UK.
© 2023 Yahoo. All rights reserved.
